Intellia Therapeutics Ownership | Who Owns Intellia Therapeutics?
Intellia Therapeutics Ownership Summary
Intellia Therapeutics is owned by 92.18% institutional investors, 1.21% insiders, and 6.61% retail investors. Ark investment management is the largest institutional shareholder, holding 12.14% of NTLA shares. ARK Innovation ETF is the top mutual fund, with 8.51% of its assets in Intellia Therapeutics shares.
NTLA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Intellia Therapeutics | 92.18% | 1.21% | 6.61% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ark investment management | 11.60M | 12.14% | $259.51M |
| Blackrock | 9.60M | 10.05% | $214.79M |
| Vanguard group | 9.10M | 9.53% | $203.66M |
| Deep track capital, lp | 4.80M | 5.03% | $107.42M |
| State street | 4.36M | 4.57% | $97.64M |
| Nikko asset management americas | 3.26M | 3.41% | $72.91M |
| Sumitomo mitsui trust | 2.99M | 2.96% | $34.89M |
| Morgan stanley | 2.34M | 2.45% | $52.32M |
| Federated hermes | 2.30M | 2.41% | $51.49M |
| Geode capital management | 2.29M | 2.40% | $51.35M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Discovery value fund | 561.56K | 6.39% | $12.57M |
| Deep track capital, lp | 4.80M | 3.21% | $107.42M |
| Contrarius investment management | 1.92M | 2.68% | $42.87M |
| Ark investment management | 11.60M | 2.30% | $259.51M |
| Himension capital (singapore) pte. | 1.03M | 1.63% | $23.05M |
| Bioimpact capital | 443.50K | 1.54% | $9.93M |
| Orchard capital management | 170.01K | 1.15% | $3.80M |
| Nikko asset management americas | 3.26M | 0.84% | $72.91M |
| Evolutionary tree capital management | 36.26K | 0.84% | $811.54K |
| Pdt partners | 227.22K | 0.48% | $5.09M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ark investment management | 11.60M | 2.30% | 606.51K |
| Deep track capital, lp | 4.80M | 3.21% | 589.22K |
| Contrarius investment management | 1.92M | 2.68% | 564.88K |
| Blackrock | 9.60M | 0.00% | 488.34K |
| Nuveen asset management | 865.63K | 0.01% | 481.76K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 781.77K | 0.00% | -3.38M |
| Rokos capital management llp | - | - | -1.14M |
| Price t rowe associates inc /md/ | 1.24M | 0.00% | -380.09K |
| Voloridge investment management | 452.45K | 0.04% | -343.07K |
| Marshall wace, llp | - | - | -335.41K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 240.41K | 0.00% | 240.41K | $5.38M |
| Mirae asset global etfs | 234.81K | 0.01% | 234.81K | $5.26M |
| Sphera funds management | 139.42K | 0.43% | 139.42K | $3.12M |
| Engineers gate manager lp | 61.53K | 0.03% | 61.53K | $1.38M |
| Corebridge financial | 51.83K | 0.01% | 51.83K | $1.16M |
Sold Out
| Holder | Change |
|---|---|
| Dinuzzo private wealth | -1.00 |
| Baldwin brothers llc/ma | -4.00 |
| Family firm | -15.00 |
| Nelson, van denburg & campbell wealth management group | -17.00 |
| Innealta capital | -18.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 290 | -5.54% | 93,104,860 | 3.35% | 92 | 1.07% | 150 | -7.41% | 84 | -4.55% |
| Jun 30, 2024 | 302 | 0.67% | 90,028,919 | -0.69% | 94 | 1.05% | 160 | 5.26% | 86 | -2.27% |
| Mar 31, 2024 | 300 | -2.28% | 90,656,601 | 6.41% | 94 | 1.03% | 152 | -11.11% | 88 | 10.00% |
| Dec 31, 2023 | 307 | 4.07% | 85,199,452 | 6.57% | 95 | 1.18% | 171 | 14.77% | 80 | 19.40% |
| Sep 30, 2023 | 295 | -1.67% | 79,946,745 | 2.21% | 90 | 1.15% | 149 | 7.97% | 67 | -11.84% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Innovation ETF | 8.67M | 8.51% | -153.07K |
| ARK Disruptive Innovation Full Composite | 8.28M | 8.15% | 159.07K |
| ARK Genomic Revolution | 3.08M | 3.03% | 517.81K |
| Vanguard Total Stock Mkt Idx Inv | 3.04M | 2.99% | 4.16K |
| SPDR® S&P Biotech ETF | 2.91M | 2.85% | -33.96K |
| ARK Genomic Revolution ETF | 2.88M | 2.83% | -118.29K |
| iShares Russell 2000 ETF | 2.73M | 2.68% | -10.50K |
| Vanguard Small Cap Index | 2.46M | 2.42% | 33.35K |
| Nikko AM ARK Disruptive Innovation A USD | 2.00M | 1.96% | -32.20K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.62M | 1.59% | 95.00K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 03, 2025 | Dube Michael P | VP, Chief Accounting Officer | Sell | $16.71K |
| Jan 03, 2025 | BASTA JAMES | EVP, General Counsel | Sell | $86.16K |
| Jan 03, 2025 | Lebwohl David | EVP, Chief Medical Officer | Sell | $116.40K |
| Jan 03, 2025 | Hicks Derek | EVP, Chief Business Officer | Sell | $79.19K |
| Jan 03, 2025 | LEONARD JOHN M | President and CEO | Sell | $326.51K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 1 |
| 2024 Q3 | - | 1 |
| 2024 Q2 | - | 1 |
| 2024 Q1 | - | 12 |
| 2023 Q4 | - | 1 |
NTLA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools